A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

Among adults with episodic migraine, fasting for 5 to 6 hours a day was linked to 49% higher odds of experiencing a same-day ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

In this video, Chandler S. Cortina, MD, MS, FACS, discusses a cohort study that highlights the importance of additional research on breast cancer screening and treatment among transgender, nonbinary ...

Opioid overdose deaths continued to rise among adolescents and young adults during a recent 5-year period, and synthetic ...

In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses KITE-363, an anti-CD19/CD20 chimeric antigen receptor T-cell therapy, being studied for patients with ...

In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix Pro, the ...

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

A subdivision of the American Diabetes Association has begun publishing a document that aims to provide comprehensive ...